Extracellular vesicles from wild-type Epstein-Barr virus-transformed B-cells export host DNA and the viral lncRNA EBER1

This study provides the first integrated multiomic profile of extracellular vesicles from wild-type EBV-transformed B-cells, revealing that they export abundant host DNA and the viral lncRNA EBER1 while containing minimal viral DNA, thereby suggesting a vesicle-mediated mechanism for delivering viral RNA to distal tissues like the CNS in multiple sclerosis.

The Gist

The Big Picture: The "Text Message" from Infected Cells

Imagine your body is a bustling city. In this city, there are security guards called B-cells. Sometimes, a sneaky virus called Epstein-Barr (EBV) hides inside these guards. EBV is like a master forger; it doesn't just sit there—it rewrites the guard's instructions and makes them act differently.

Scientists have long known that EBV is linked to Multiple Sclerosis (MS), a disease where the body's security system accidentally attacks the brain's wiring. But there was a big mystery: How does a virus hiding in a blood cell talk to the brain? The virus isn't usually active enough to travel there on its own.

This paper suggests the answer: The infected guards are sending out "text messages" in tiny bubbles.

The "Bubbles" (Extracellular Vesicles)

Think of Extracellular Vesicles (EVs) as tiny, waterproof balloons that cells blow up and release into the bloodstream.

• Normal cells send out these balloons to say, "Hey, I'm here," or "We need help."
• EBV-infected cells also send these out, but they are packing them with weird cargo.

The researchers took these balloons from people with MS and healthy people, popped them open, and looked at what was inside. They wanted to see if the virus was hiding inside the balloons.

The Surprise Findings: What's Inside the Bubbles?

The team used high-tech microscopes and DNA scanners to inspect the contents of these bubbles. Here is what they found:

1. The "Hostage" DNA (Human DNA)

They found a lot of human DNA inside the bubbles.

• The Analogy: Imagine the infected cell is a factory. It's shredding its own blueprints (DNA) and stuffing the shredded pieces into the balloons.
• Two Types of Shredding:
  • The "Surface Scum": Some DNA was stuck to the outside of the balloon. It was loose and easily washed away.
  • The "Protected Treasure": Other DNA was wrapped tightly in a protective case (called a nucleosome) and hidden deep inside the balloon. This DNA was safe from enzymes that usually eat it.
• The Twist: Even though the cell was infected with a virus, almost all the DNA inside the bubbles was human, not viral. The virus wasn't sending its own genetic code in these bubbles.

2. The Viral "Sticky Note" (EBER1)

While the virus didn't send its full "blueprint" (genomic DNA), it did send a very specific, tiny note called EBER1.

• The Analogy: Imagine the virus is a spy. Instead of sending the whole spy manual (which is huge and risky), it sends a single, sticky note that says, "I am here. Pay attention to me."
• The Discovery: This sticky note (EBER1) was the most common viral item found in the bubbles. It was packed in there in huge numbers.
• Why it matters: Scientists have previously found this exact sticky note (EBER1) inside the brains of people with MS. This paper explains how it got there: The infected blood cells packed these notes into balloons, sent them through the bloodstream, and the balloons floated right into the brain.

Why This Changes Everything

Before this study, scientists thought that for the virus to affect the brain, it had to be an active, infectious virus traveling there. But this paper suggests a different story:

1. The Virus is a "Silent Passenger": The virus stays hidden in the blood cells.
2. The Bubbles are the Delivery Service: The infected cells release these tiny balloons (EVs).
3. The Message is Delivered: The balloons carry the viral "sticky note" (EBER1) across the brain's security fence (the blood-brain barrier).
4. The Alarm is Triggered: When the brain cells receive these balloons, they read the note and get confused or angry, potentially starting the inflammation that causes MS.

The Bottom Line

This research is like finding the missing link in a detective story. It shows that EBV-infected cells don't need to be active or dangerous to cause trouble. They just need to send out their tiny, bubble-packed "text messages" (containing human DNA and the viral note EBER1) to the brain.

This discovery gives scientists a new target. If we can stop these bubbles from being made, or stop them from delivering their message to the brain, we might be able to treat or prevent Multiple Sclerosis.

Technical Summary

1. Problem Statement

Epstein–Barr virus (EBV) is a ubiquitous gammaherpesvirus strongly linked to Multiple Sclerosis (MS) and other autoimmune diseases. While EBV establishes lifelong latency in memory B-cells, the mechanisms by which these infected cells communicate with distal tissues (such as the Central Nervous System) in the absence of active viral replication remain unclear.

• The Gap: Previous studies relied heavily on laboratory-transformed lymphoblastoid cell lines (LCLs) using prototype strains (e.g., B95-8) that harbor genomic deletions and do not reflect wild-type viral diversity.
• The Mystery: Viral RNA (specifically the long non-coding RNA EBER1) has been detected in MS brain tissue, yet infectious virus is rarely found there. The mechanism for this viral RNA dissemination from peripheral B-cells to the CNS is unresolved.
• The Hypothesis: Extracellular vesicles (EVs) may serve as a vehicle for transporting viral and host cargo across biological barriers (like the blood-brain barrier), but the integrated multiomic cargo of EVs from wild-type EBV-infected cells has not been comprehensively defined.

2. Methodology

The authors utilized Spontaneous Lymphoblastoid Cell Lines (SLCLs) derived from normal donors and patients with stable or active MS. These lines were transformed ex vivo by the donors' endogenous, wild-type EBV, avoiding the artifacts of laboratory strains.

Experimental Workflow:

1. EV Isolation: Small EVs (sEVs) were isolated from culture supernatants using differential ultracentrifugation (separating sEVs from potential virions).
2. Characterization:
   • Physical: Microfluidic Resistive Pulse Sensing (MRPS) for size/concentration; Transmission Electron Microscopy (TEM) for morphology.
   • Surface Profiling: Multiplex bead-based flow cytometry (MACSPlex) for tetraspanins (CD9, CD63, CD81) and B-cell markers.
3. Multiomic Profiling:
   • Proteomics: Data-independent acquisition mass spectrometry (DIA-MS) to identify protein cargo.
   • Genomics (DNA): Whole-genome sequencing (WGS) of EV-associated DNA. A critical step involved DNase treatment to distinguish between DNA on the vesicle surface (coronal) versus DNA protected inside the lumen.
   • Transcriptomics (RNA): Total stranded RNA sequencing (RNASeq) to profile host and viral transcripts.
   • Validation: Droplet digital PCR (ddPCR) for quantitative viral RNA; Super-resolution microscopy (dSTORM) to visualize the localization of DNA and RNA within individual vesicles.

3. Key Contributions

• First Wild-Type Profile: This study provides the first integrated multiomic map of sEVs derived from B-cells transformed by naturally acquired, wild-type EBV, correcting biases introduced by laboratory strains.
• Dual Compartment DNA Discovery: The study identifies two distinct structural compartments for DNA within EVs:
  1. Coronal (Surface): High-molecular-weight, DNase-sensitive DNA fragments.
  2. Luminal (Internal): DNase-resistant, nucleosome-sized (~130–150 bp) DNA protected within the vesicle.
• Selective Viral RNA Packaging: The study demonstrates that while viral genomic DNA is minimal, the viral long non-coding RNA EBER1 is selectively and robustly enriched in EVs.

4. Key Results

A. EV Identity and Purity

• SLCL-derived sEVs were ~50–200 nm, cup-shaped, and free of intact virions.
• They expressed canonical EV markers (CD9, CD63, CD81) and B-cell markers (CD19, CD20, MHC-I/II), confirming their cellular origin.

B. Proteomic Landscape

• Over 6,000 shared proteins were identified.
• Enrichment: sEVs were enriched in nucleic acid-binding and chromatin-associated proteins (histones H2A, H2AX, H4; topoisomerase 1).
• Disease Specificity: Stable MS lines showed enrichment in chromatin-related pathways, while active MS lines showed enrichment in B-cell receptor components.
• Viral Proteins: 40 EBV-encoded proteins were detected (including EBNA1, LMP2, MCP), but they were not the most abundant species.

C. DNA Cargo (The Two Compartments)

• Host vs. Viral: EV-associated DNA was overwhelmingly host-derived and broadly distributed across the genome. EBV genomic DNA was minimal.
• Structural Distinction:
  • Coronal DNA: High-molecular-weight fragments (600–7,000 bp) that were sensitive to DNase, suggesting they are co-isolated or surface-associated.
  • Luminal DNA: A distinct population of ~130–150 bp fragments that persisted after DNase treatment. This size corresponds to nucleosome-protected DNA, confirmed by super-resolution imaging showing DNA co-localized with internal actin.
• Implication: The export of chromatinized DNA suggests a regulated process, potentially linked to DNA repair or nuclear blebbing.

D. RNA Cargo and EBER1 Enrichment

• Viral Transcripts: 59 EBV-encoded RNAs were detected.
• EBER1 Dominance: The viral lncRNA EBER1 was the most abundant viral transcript across all donor groups.
• Quantification: ddPCR confirmed EBER1 presence at 14–29 copies per $10^6$ vesicles. In contrast, lytic transcripts (e.g., BZLF1, BFRF3) were nearly undetectable (<1 copy).
• Localization: Super-resolution microscopy confirmed EBER1 is physically incorporated within individual vesicles, co-localizing with tetraspanin membranes.

5. Significance

• Mechanism for CNS Infiltration: The findings provide a plausible mechanism for how EBV-infected B-cells deliver viral RNA to the CNS. Since EVs can traverse the blood-brain barrier and EBER1 is known to activate innate immunity (via RIG-I and TLR3), EV-mediated transfer of EBER1 could drive neuroinflammation in MS without the need for infectious virus.
• Redefining EV Biology: The discovery of nucleosome-sized, luminal DNA challenges the view of EVs as simple carriers of free nucleic acids, suggesting they can transport structured chromatin fragments.
• Wild-Type Relevance: By using wild-type EBV, the study reveals a broader repertoire of viral cargo (including BART miRNAs and other ORFs) compared to studies using the deletion-prone B95-8 strain, offering a more accurate model of natural infection.
• Therapeutic Implications: Understanding that EVs carry specific viral lncRNAs (EBER1) and host chromatin fragments opens new avenues for biomarker discovery (e.g., detecting EBER1 in biofluids) and therapeutic targeting of intercellular communication in MS.

In summary, this paper establishes that wild-type EBV-transformed B-cells export a specific multiomic signature via EVs: host chromatin (in two distinct forms) and the viral lncRNA EBER1, providing a novel pathway for viral influence on distal tissues in autoimmune disease.